'Other' targets in lung cancer

Share :
Published: 25 Jul 2016
Views: 2072
Rating:
Save
Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA

Dr Garon speaks with ecancertv at the Best of ASCO 2016 about targetable mutations in lung cancer.

With examples of BRAF and RET mutations, he discusses the clinical significance of sequencing data in achieving a patient's best possible responses to therapy.

For more on lung cancer sequencing, watch Dr Bruce Johnson speaking to ecancertv at WIN 2016.